Warby Parker Inc. (WRBY) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 163.48M USD | Liabilities, Current |
| Cash and equivalents | 292.67M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 2.08M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 42.10M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $163.48M | $292.67M | (m) | $2.08M | $42.10M | (m) |
| 2026-03-31 | (m) | $153.28M | $288.25M | (m) | $1.76M | $46.45M | (m) |
| 2025-12-31 | (m) | $150.13M | $286.36M | (m) | $3.29M | $44.51M | (m) |
| 2025-09-30 | (m) | $132.06M | $280.36M | (m) | $1.14M | $45.59M | (m) |
| 2025-06-30 | (m) | $135.53M | $286.38M | (m) | $1.14M | $43.27M | (m) |
| 2025-03-31 | (m) | $122.61M | $265.07M | (m) | $1.47M | $48.61M | (m) |
| 2024-12-31 | (m) | $130.35M | $254.16M | (m) | $1.95M | $52.34M | (m) |
| 2024-09-30 | (m) | $130.12M | $251.03M | (m) | $1.09M | $52.77M | (m) |
| 2024-06-30 | (m) | $121.03M | $237.96M | (m) | $1.21M | $53.34M | (m) |
| 2024-03-31 | (m) | $118.54M | $220.38M | (m) | $1.17M | $56.45M | (m) |
| 2023-12-31 | (m) | $127.09M | $216.89M | (m) | $1.78M | $62.23M | (m) |
| 2023-09-30 | (m) | $121.81M | $215.97M | (m) | $721.00K | $63.62M | (m) |
| 2023-06-30 | (m) | $110.43M | $212.66M | (m) | $1.18M | $59.83M | (m) |
| 2023-03-31 | (m) | $111.04M | $204.26M | (m) | $962.00K | $64.41M | (m) |
| 2022-12-31 | (m) | $129.56M | $208.59M | (m) | $1.44M | $68.85M | (m) |
| 2022-09-30 | (m) | $111.48M | $197.88M | (m) | $1.11M | $70.57M | (m) |
| 2022-06-30 | (m) | $119.86M | $211.60M | (m) | $901.00K | $70.79M | (m) |
| 2022-03-31 | (m) | $128.74M | $230.32M | (m) | $830.00K | $64.25M | (m) |
| 2021-12-31 | (m) | $118.10M | $256.42M | (m) | $992.00K | $57.09M | (m) |
| 2021-09-30 | (m) | $134.35M | $266.24M | (m) | $822.00K | $51.44M | (m) |
| 2020-12-31 | (m) | $105.33M | $314.08M | (m) | $601.00K | $38.47M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |